These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bridging Translation by Improving Preclinical Study Design in AKI. de Caestecker M; Humphreys BD; Liu KD; Fissell WH; Cerda J; Nolin TD; Askenazi D; Mour G; Harrell FE; Pullen N; Okusa MD; Faubel S; J Am Soc Nephrol; 2015 Dec; 26(12):2905-16. PubMed ID: 26538634 [TBL] [Abstract][Full Text] [Related]
3. From Reproducibility to Translation in Neurodegenerative Disease. Zeiss CJ ILAR J; 2017 Jul; 58(1):106-114. PubMed ID: 28444192 [TBL] [Abstract][Full Text] [Related]
4. Translational intracerebral hemorrhage: a need for transparent descriptions of fresh tissue sampling and preclinical model quality. Chang CF; Cai L; Wang J Transl Stroke Res; 2015 Oct; 6(5):384-9. PubMed ID: 25907620 [TBL] [Abstract][Full Text] [Related]
5. Preclinical mouse solid tumour models: status quo, challenges and perspectives. Gengenbacher N; Singhal M; Augustin HG Nat Rev Cancer; 2017 Dec; 17(12):751-765. PubMed ID: 29077691 [TBL] [Abstract][Full Text] [Related]
6. Practical approaches to improving translatability and reproducibility in preclinical pain research. Soliman N; Denk F Brain Behav Immun; 2024 Jan; 115():38-42. PubMed ID: 37793487 [TBL] [Abstract][Full Text] [Related]
7. Animal models of Huntington's disease for translation to the clinic: best practices. Menalled L; Brunner D Mov Disord; 2014 Sep; 29(11):1375-90. PubMed ID: 25216369 [TBL] [Abstract][Full Text] [Related]
8. Single-subject research designs in pediatric rehabilitation: a valuable step towards knowledge translation. Romeiser-Logan L; Slaughter R; Hickman R Dev Med Child Neurol; 2017 Jun; 59(6):574-580. PubMed ID: 28224606 [TBL] [Abstract][Full Text] [Related]
9. Miniature Swine for Preclinical Modeling of Complexities of Human Disease for Translational Scientific Discovery and Accelerated Development of Therapies and Medical Devices. Schomberg DT; Tellez A; Meudt JJ; Brady DA; Dillon KN; Arowolo FK; Wicks J; Rousselle SD; Shanmuganayagam D Toxicol Pathol; 2016 Apr; 44(3):299-314. PubMed ID: 26839324 [TBL] [Abstract][Full Text] [Related]
10. [Preclinical research. Seal of approval translational medicine]. Hermann S; Pichler B; Kotzerke J Nuklearmedizin; 2013 Dec; 52(6):N53-4. PubMed ID: 24337015 [No Abstract] [Full Text] [Related]
12. Pharmaco-EEG Studies in Animals: A History-Based Introduction to Contemporary Translational Applications. Drinkenburg WH; Ahnaou A; Ruigt GS Neuropsychobiology; 2015; 72(3-4):139-50. PubMed ID: 26901675 [TBL] [Abstract][Full Text] [Related]
13. Translational research challenges: finding the right animal models. Prabhakar S J Investig Med; 2012 Dec; 60(8):1141-6. PubMed ID: 23072902 [TBL] [Abstract][Full Text] [Related]
14. Guidelines for translational research in heart failure. Lara-Pezzi E; Menasché P; Trouvin JH; Badimón L; Ioannidis JP; Wu JC; Hill JA; Koch WJ; De Felice AF; de Waele P; Steenwinckel V; Hajjar RJ; Zeiher AM J Cardiovasc Transl Res; 2015 Feb; 8(1):3-22. PubMed ID: 25604959 [TBL] [Abstract][Full Text] [Related]
15. [What to do if statistical power is low? A practical strategy for pre-post-designs]. Müller J; Manz R; Hoyer J Psychother Psychosom Med Psychol; 2002; 52(9-10):408-16. PubMed ID: 12355348 [TBL] [Abstract][Full Text] [Related]
16. Randomized block experimental designs can increase the power and reproducibility of laboratory animal experiments. Festing MF ILAR J; 2014; 55(3):472-6. PubMed ID: 25541548 [TBL] [Abstract][Full Text] [Related]
17. Assessing statistical precision, power, and robustness of alternative experimental designs for two color microarray platforms based on mixed effects models. Tempelman RJ Vet Immunol Immunopathol; 2005 May; 105(3-4):175-86. PubMed ID: 15808299 [TBL] [Abstract][Full Text] [Related]
18. Translatability: what does it mean in drug discovery? Tudor M; Hermes J; Li J Drug Discov Today; 2016 Jun; 21(6):865-7. PubMed ID: 27021791 [No Abstract] [Full Text] [Related]
19. Mixed-strain housing for female C57BL/6, DBA/2, and BALB/c mice: validating a split-plot design that promotes refinement and reduction. Walker M; Fureix C; Palme R; Newman JA; Ahloy Dallaire J; Mason G BMC Med Res Methodol; 2016 Jan; 16():11. PubMed ID: 26817696 [TBL] [Abstract][Full Text] [Related]
20. Fit-for purpose use of mouse models to improve predictivity of cancer therapeutics evaluation. Wartha K; Herting F; Hasmann M Pharmacol Ther; 2014 Jun; 142(3):351-61. PubMed ID: 24412280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]